Definitive Healthcare

How it happened

Definitive Healthcare sells a 'healthcare commercial intelligence' SaaS platform — data and analytics on hospitals, physicians and the health-care market used by life-sciences and medtech sales teams. It went public in September 2021 at roughly a $3.9B valuation amid the health-data boom. Growth decelerated sharply as customers cut software spending, and the stock fell about 96%, leaving the company worth around $150M. Employee reviews tracked the grind from inside: successive layoff rounds starting with a 6% cut in January 2023, roles moving offshore, and a churn of CEOs and reorganizations that kept resetting strategy mid-slide.

Employee accounts paraphrase anonymous, unverified reviews posted publicly on Glassdoor ↗. See our methodology.